Novel Drug Authorized for Critically Ill COVID-19 Patients
MedPage Today) — The FDA has issued an emergency use authorization (EUA) for vilobelimab (Gohibic) to treat critically ill adults with COVID-19.
In the EUA for the first-in-class monoclonal anti-human complement factor C5a antibody, the agency…
Read More
0
